Combination of preoperative fibrinogen and neutrophil to lymphocyte ratio is a predictive prognostic factor in esophageal squamous cell carcinoma systematic review

Jinlan Lin, Tianxing Guo, Xiaojie Pan
{"title":"Combination of preoperative fibrinogen and neutrophil to lymphocyte ratio is a predictive prognostic factor in esophageal squamous cell carcinoma systematic review","authors":"Jinlan Lin, Tianxing Guo, Xiaojie Pan","doi":"10.3760/CMA.J.ISSN.1001-9030.2019.12.047","DOIUrl":null,"url":null,"abstract":"Objective \nTo explored the clinical value of preoperative fibrinogen and neutrophil to lymphocyte ratio (NLR) in patients with esophageal squamous cell carcinoma (ESCC) in this study. \n \n \nMethods \n327 patients undergoing ESCC radical surgery was performed to evaluate prognostic factors for overall survival (OS) by univariate and multivariate COX regression analyses. The optimal cut-off values for fibrinogen and NLR were 3.09 g/L and 1.89, respectively. The fibrinogen and NLR (F-NLR) scoring criteria were defined according to the cut-off criteria. High fibrinogen (≥3.09 g/L) and high NLR (≥1.89) were defined as 2 points, patients with high fibrinogen or high NLR were defined as 1 point, and neither hyperfibrinogen or high NLR scored 0 points. \n \n \nResults \nThe OS of patients with high fibrinogen ESCC was significantly poor than patients with low fibrinogen (31.4% vs. 63.3%, P<0.01), while the OS of patients with elevated NLR was also significantly poor than patients with low NLR (40.4% vs. 50.3%). The F-NLR score was significantly correlated with tumor size (P<0.01) and pathological stage (P<0.01). The 5-year OS rates for F-NLR score groups 0, 1, and 2 were 69.1%, 42.6%, and 31.9%, respectively, there were significant differences between subgroups (P<0.01). Multivariate analysis showed that tumor size (P<0.01), pathological stage (P<0.01), and F-NLR (P<0.01) were independent prognostic factors for OS. \n \n \nConclusion \nPreoperative F-NLR score can be used as an independent prognostic indicator for ESCC patients. \n \n \nKey words: \nEsophageal squamous cell carcinoma; Fibrinogen; Platelet to lymphocyte ratio; Prognostic indicator","PeriodicalId":10065,"journal":{"name":"中华实验外科杂志","volume":"36 1","pages":"2279-2282"},"PeriodicalIF":0.0000,"publicationDate":"2019-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华实验外科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1001-9030.2019.12.047","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective To explored the clinical value of preoperative fibrinogen and neutrophil to lymphocyte ratio (NLR) in patients with esophageal squamous cell carcinoma (ESCC) in this study. Methods 327 patients undergoing ESCC radical surgery was performed to evaluate prognostic factors for overall survival (OS) by univariate and multivariate COX regression analyses. The optimal cut-off values for fibrinogen and NLR were 3.09 g/L and 1.89, respectively. The fibrinogen and NLR (F-NLR) scoring criteria were defined according to the cut-off criteria. High fibrinogen (≥3.09 g/L) and high NLR (≥1.89) were defined as 2 points, patients with high fibrinogen or high NLR were defined as 1 point, and neither hyperfibrinogen or high NLR scored 0 points. Results The OS of patients with high fibrinogen ESCC was significantly poor than patients with low fibrinogen (31.4% vs. 63.3%, P<0.01), while the OS of patients with elevated NLR was also significantly poor than patients with low NLR (40.4% vs. 50.3%). The F-NLR score was significantly correlated with tumor size (P<0.01) and pathological stage (P<0.01). The 5-year OS rates for F-NLR score groups 0, 1, and 2 were 69.1%, 42.6%, and 31.9%, respectively, there were significant differences between subgroups (P<0.01). Multivariate analysis showed that tumor size (P<0.01), pathological stage (P<0.01), and F-NLR (P<0.01) were independent prognostic factors for OS. Conclusion Preoperative F-NLR score can be used as an independent prognostic indicator for ESCC patients. Key words: Esophageal squamous cell carcinoma; Fibrinogen; Platelet to lymphocyte ratio; Prognostic indicator
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
术前纤维蛋白原和中性粒细胞/淋巴细胞比值是食管鳞状细胞癌预后的预测因素
目的探讨食管鳞状细胞癌(ESCC)患者术前纤维蛋白原及中性粒细胞/淋巴细胞比值(NLR)的临床意义。方法对327例接受ESCC根治术的患者进行单因素和多因素COX回归分析,评价影响总生存期(OS)的预后因素。纤维蛋白原和NLR的最佳临界值分别为3.09 g/L和1.89 g/L。根据截止标准确定纤维蛋白原和NLR (F-NLR)评分标准。高纤维蛋白原(≥3.09 g/L)和高NLR(≥1.89)定义为2分,高纤维蛋白原或高NLR定义为1分,高纤维蛋白原和高NLR均为0分。结果高纤维蛋白原ESCC患者的OS明显差于低纤维蛋白原患者(31.4%比63.3%,P<0.01), NLR升高患者的OS也明显差于低NLR患者(40.4%比50.3%)。F-NLR评分与肿瘤大小(P<0.01)、病理分期(P<0.01)显著相关。F-NLR评分0、1、2组5年OS率分别为69.1%、42.6%、31.9%,亚组间差异有统计学意义(P<0.01)。多因素分析显示,肿瘤大小(P<0.01)、病理分期(P<0.01)、F-NLR (P<0.01)是影响OS预后的独立因素。结论术前F-NLR评分可作为ESCC患者独立的预后指标。关键词:食管鳞状细胞癌;纤维蛋白原;血小板与淋巴细胞比值;预后的指标
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
18226
期刊介绍:
期刊最新文献
Application of polybrene to increase transfection efficiency of lentiviral vector in bone marrow derived dendritic cells MicroRNA-224 mediates lipopolysaccharide-induced injury of pulmonary microvascular endothelium cells via regulating p21 Expression and clinical significance of circulating microRNA-375 and tissue Yes-associated protein 1 in colorectal cancer patients Expression and prognosis of N-α-acetyltransferase gene 10 in breast cancer Expression of human cartilage glycoprotein 39 in peripheral blood and tissues in renal cell carcinoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1